North American Ginseng Capsules
Natural health product licensed in Canada
- Other names
- N.A Ginseng Capsules, Pure North American Ginseng Capsules
- Licence holder
- PhytoKy Health Science Inc.
- NPN or DIN-HM
- 80098106
- Status
- Active licence
- Licence date
- 2 April 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | minimum: 1 Capsule ; maximum: 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
(Traditionally) used in Herbal Medicine to help relieve restlessness and/or nervousness (calmative). Used in Herbal Medicine as an adaptogen to help maintain a healthy immune system. Used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner/health care provider/health care professional/ doctor/ physician prior to use if you are taking blood thinners or digoxin. Consult a health care practitioner/health care provider/health care professional/ doctor/ physician prior to use if you have diabetes.
Source
Official Health Canada record, licence 80098106
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.